By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlycoMimetics, Inc. 

14915 Broschart Road, Suite 200

Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax:




Company News
GlycoMimetics, Inc. (GLYC) Announces Publication Of New Preclinical Data With GMI-1271 In Science Translational Medicine 5/26/2016 11:39:01 AM
3 Biotech Stocks Flying High Under-the-Radar 5/26/2016 6:31:07 AM
Initial Efficacy Data For GlycoMimetics, Inc. (GLYC)’ GMI-1271 Combined With Chemotherapy In Patients With AML To Be Presented At European Hematology Association 21st Congress 5/19/2016 12:52:39 PM
GlycoMimetics, Inc. (GLYC) Reports First Quarter 2016 Results 5/4/2016 11:01:10 AM
GlycoMimetics, Inc. (GLYC) Data On GMI-1271 Treatment Of Acetaminophen-Triggered Liver Toxicity To Be Presented At “Digestive Disease Week” Conference 4/26/2016 12:30:06 PM
GlycoMimetics, Inc. (GLYC) Appoints ImmunoGen (IMGN) CEO Daniel Junius To Board Of Directors 3/21/2016 10:28:16 AM
GlycoMimetics, Inc. (GLYC) To Present New Preclinical Data On Its E-Selectin-CXCR4 Dual Antagonist At AACR Annual Meeting 2016 3/17/2016 10:51:25 AM
GlycoMimetics, Inc. (GLYC) Announces Initial Clinical Data From Phase I Portion Of Clinical Trial Of GMI-1271 In AML Patients 3/2/2016 10:30:03 AM
GlycoMimetics, Inc. (GLYC) Reports Fourth Quarter And Year-End 2015 Results 3/1/2016 11:55:40 AM
GlycoMimetics, Inc. (GLYC) To Present At 18th Annual BIO CEO & Investor Conference 2/2/2016 11:06:01 AM